Description
Human Apolipoprotein AII (Apo AII) | ABMC-P05
Concentration: | 1 mg / ml, determined by the Lowry method |
Source: | From fresh human plasma that has tested negative for Hepatitis C, HIV-I and HIV-II antibodies as well as Hepatitis surface antigens. |
Purification: | After series ultracentrifugations, High Density Lipoprotein (HDL) is isolated from human plasma. Apo AII is purified from delipidated HDL, followed by gel-filtration and DEAE-Sepharcyl chromatography. |
Purity: | ≥ 98% by SDS-PAGE |
Buffer: | 20 mM Tris-HCl, 140 mM NaCl, 0.02% NaN3, 0.5 mM EDTA, pH 7.4. |
Storage: | -20°C for long-term storage, 4°C for short- term storage. Aliquot to avoid repeated freezing and thawing. |
IMPORTANCE
Apo AII comprises 25% of HDL. It exists in human plasma as a dimer of 2 identical chains of 77 amino acid residues, joined by disulfide. The molecular weight is reported to be 8.7 kDa for a single chain (Brewer et al., 1972).
Studies on mouse reported that apo AII may be proatherogenic (Warden et al., 1993); however, case-control study in the large European Prospective Investigation demonstrated that plasma Apo AII concentrations were strongly inversely correlated with CHD events (Birjmohun et al., 2007).